Analysts reiterate bullish ratings on both Valeant Pharmaceuticals Intl Inc (NYSE:VRX) as investors hope that the new Walgreens deal will fill Philidor’s void, …
KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) plunged 53% in pre-market trading this morning to $11.03 after CEO Martin Shkreli was arrested earlier today on security fraud …
Considerable strength remains visible among biotechnology stocks, as reflected by the 2.25 percent gain being posted by the iShares NASDAQ Biotechnology Index today.
Analysts are weighing in today on the technology giant Apple Inc. (NASDAQ:AAPL), financial giant Bank of America Corp (NYSE:BAC), and Canadian drug company Valeant Pharmaceuticals Intl …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Zogenix, Inc. (NASDAQ:ZGNX) both released exciting announcements yesterday, precipitating bullish ratings by analysts.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced updated financial guidance for the fourth quarter and full year 2015 as well as new guidance for …
Considerable strength remains visible among biotechnology stocks, as reflected by the 3 percent gain being posted by the iShares NASDAQ Biotechnology Index today. The …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced new fulfillment agreements with Walgreens while indicating it intends to extend this distribution model to additional participating …
Healthcare analysts at UBS and Brean Capital weighed in on the controversial drug giant Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and bio-pharmaceutical company Horizon Pharma PLC (NASDAQ:HZNP). The analysts …
Stifel and FBR Capital analysts came out today with new ratings and price targets on a handful of healthcare stocks. Lets take a look …
